PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
21.69%
Net income growth above 1.5x AVGO's 9.27%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
No Data
No Data available this quarter, please select a different quarter.
96.30%
Well above AVGO's 113.95% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-28.00%
Negative yoy SBC while AVGO is 16.20%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
140.76%
Slight usage while AVGO is negative at -51.27%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
19.70%
AR growth while AVGO is negative at -173.02%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
137.50%
Some inventory rise while AVGO is negative at -483.87%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
291.67%
AP growth well above AVGO's 290.35%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
205.85%
Some yoy usage while AVGO is negative at -311.11%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-110.00%
Negative yoy while AVGO is 0.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
87.79%
Operating cash flow growth above 1.5x AVGO's 4.61%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-23.18%
Negative yoy CapEx while AVGO is 0.39%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
23.18%
Less M&A spending yoy vs. AVGO's 91.89%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-7.79%
Negative yoy purchasing while AVGO stands at 100.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-27.27%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-32.87%
We reduce yoy other investing while AVGO is 99.50%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-6000.00%
We reduce yoy invests while AVGO stands at 47.67%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
We repay more while AVGO is negative at -50.00%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-9.52%
Both yoy lines negative, with AVGO at -53.93%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.